GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OliX Pharmaceuticals Inc (XKRX:226950) » Definitions » PB Ratio

OliX Pharmaceuticals (XKRX:226950) PB Ratio : 46.60 (As of Apr. 11, 2025)


View and export this data going back to 2018. Start your Free Trial

What is OliX Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-11), OliX Pharmaceuticals's share price is ₩48250.00. OliX Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2024 was ₩1,035.44. Hence, OliX Pharmaceuticals's PB Ratio of today is 46.60.

The historical rank and industry rank for OliX Pharmaceuticals's PB Ratio or its related term are showing as below:

XKRX:226950' s PB Ratio Range Over the Past 10 Years
Min: 3.37   Med: 7.37   Max: 56.79
Current: 46.6

During the past 11 years, OliX Pharmaceuticals's highest PB Ratio was 56.79. The lowest was 3.37. And the median was 7.37.

XKRX:226950's PB Ratio is ranked worse than
98.68% of 1284 companies
in the Biotechnology industry
Industry Median: 2.02 vs XKRX:226950: 46.60

During the past 12 months, OliX Pharmaceuticals's average Book Value Per Share Growth Rate was -66.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -8.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -12.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 11.50% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of OliX Pharmaceuticals was 74.10% per year. The lowest was -31.60% per year. And the median was 18.40% per year.

Back to Basics: PB Ratio


OliX Pharmaceuticals PB Ratio Historical Data

The historical data trend for OliX Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OliX Pharmaceuticals PB Ratio Chart

OliX Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.04 30.33 4.33 4.73 18.60

OliX Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.73 7.60 5.68 17.80 18.60

Competitive Comparison of OliX Pharmaceuticals's PB Ratio

For the Biotechnology subindustry, OliX Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OliX Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OliX Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where OliX Pharmaceuticals's PB Ratio falls into.


;
;

OliX Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

OliX Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=48250.00/1035.439
=46.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


OliX Pharmaceuticals  (XKRX:226950) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


OliX Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of OliX Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OliX Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 1014 Gwanggyo Ace Tower 1, Daehak 4-ro, Yeongtong-gu, Gyeonggi, Suwon, KOR, 16226
OliX Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in developing RNA interference (RNAi) technology therapeutics for dermal, ophthalmic and pulmonary diseases. The company's pipeline products include OLX101, OLX201, OLX301, OLX102, and others.

OliX Pharmaceuticals Headlines

No Headlines